In Vivo is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Critical Therapeutics Inc.

Division of Chiesi Farmaceutici SPA
www.crtx.com

Latest From Critical Therapeutics Inc.

Cornerstone Buys EKR Therapeutics To Expand Hospital Growth Strategy

Cornerstone gains two commercial products for the acute-care hospital setting, Cardene and Retavase, with the acquisition of EKR Therapeutics for $125 million upfront and potential milestones.

BioPharmaceutical Strategy

Dr Trevor Phillips joins Vectura

Vectura Group, a company developing inhaled therapies for the treatment of respiratory diseases, has appointed Dr Trevor Phillips president of its US operations. Dr Phillips has held a number of senior roles in the pharmaceutical industry, including serving as CEO and president of Critical Therapeutics, following six years as the company's chief operating officer. He has also worked at Sepracor, Scotia Pharmaceuticals, Accenture, Glaxo Wellcome Research and Development and Simbec Research.

Companies

The A-List: 2007's Trend Shaping Series A Financings

In 2007, what did Series A venture investments reveal about the state of the health care industry? It was very healthy, thank you. There were quite a few deals to choose from, and numbers demonstrated continued growth in diagnostics fundraising, a resurgence in vaccines, and evidence of pharma's interest in proof-of-concept projects and large-molecule platforms. Medical device investors, meanwhile, remain enamored with concept companies seeking to blend electronics-such as neurostimulation or miniature sensors-with devices.
BioPharmaceutical Medical Device

Dealmaking Roundup February 2007

Summary of recent device mergers and acquisitions, alliances, and financings.
Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
  • Therapeutic Areas
  • Inflammation
  • Respiratory, Pulmonary
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Chiesi Farmaceutici SPA
  • Senior Management
  • Trevor Phillips, PhD, Pres. & CEO
    Thomas P Kelly, CFO & SVP, Fin. & Corp. Dev.
    Roger Heerman, VP, Sales & Mktg.
  • Contact Info
  • Critical Therapeutics Inc.
    Phone: (781) 402-5700
    60 Westview St.
    Lexington, MA 02421
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register